Tiffany Sepp has over 20 years of experience in clinical development, and led teams taking multiple rare disease antisense oligonucleotides into the clinic. A graduate of UC San Diego, she has successfully led clinical programs for pharmaceutical companies of all sizes in a variety of therapeutic areas. In 2012, Vanguard Clinical, Inc. was born from her passion for bringing new treatments to market.

Today, Tiffany leads a growing team of clinical professionals across the country while also personally consulting on a select number of Vanguard Clinical’s projects, like AlphaRose.